# OrganaBio > OrganaBio is a Miami-based biotech company (founded 2018) that supplies premium cell and gene therapy starting materials and provides complete development, manufacturing, and clinical trial support services. FDA-registered blood and tissue establishment with wholly-owned subsidiaries GaiaGift (birth tissue) and HemaCenter (leukapheresis). Operates facilities in Miami, FL and Irvine, CA. ## Key Facts - 99.1% cell viability across 3,000+ clinical samples processed - < 30 minutes from sample receipt to processing - 99.9% processing accuracy - 500+ recallable donors - Products available in both research-grade (RUO) and cGMP-compliant formats - All collections under IRB-approved protocols with FDA 21 CFR 1271 donor screening ## Products - [LeukoPAK-FRSH — Fresh Leukopaks](https://www.organabio.com/product/leukopak-frsh/): Fresh leukopaks from healthy adult peripheral blood for CAR-T, cell therapy, and gene therapy starting material. - [LeukoPAK-FRZN — Cryopreserved Leukopaks](https://www.organabio.com/product/leukopak-frzn/): Cryopreserved leukopaks from adult peripheral blood for CAR-T, cell therapy, and gene therapy research. - [LeukoPAK-T-PB — Human Pan T Cells](https://www.organabio.com/product/leukopak-t-pb/): Cryopreserved human pan T cells (CD3+, negatively isolated) from adult peripheral blood. - [LeukoPAK-PBMC-PB — PBMCs](https://www.organabio.com/product/leukopak-pbmc-pb/): High-quality cryopreserved peripheral blood mononuclear cells for immuno-oncology, vaccine development, and autoimmune research. - [LeukoPAK-NK-PB — NK Cells](https://www.organabio.com/product/leukopak-nk-pb/): Cryopreserved peripheral blood-derived CD56+ natural killer cells for immuno-oncology and NK cell therapy development. - [ImmunoPAC-T-CB — Cord Blood T Cells](https://www.organabio.com/product/immunopac-t-cb/): High-purity cryopreserved cord blood-derived pan T cells (CD3+) for CAR-T development and allogeneic therapy. - [ImmunoPAC-NK-CB — Cord Blood NK Cells](https://www.organabio.com/product/immunopac-nk-cb/): Cryopreserved cord blood-derived CD56+ NK cells for NK cell therapy development and cytotoxicity assays. - [HematoPAC-HSC-CB — CD34+ Stem Cells](https://www.organabio.com/product/hematopac-hsc-cb/): Cryopreserved cord blood-derived CD34+ hematopoietic stem cells for engraftment studies and gene therapy development. - [HematoPAC-CB-FRSH — Fresh Cord Blood](https://www.organabio.com/product/hematopac-cb-frsh/): Freshly collected umbilical cord blood units for hematopoietic stem cell research and gene therapy applications. - [MesenPAC-MSC-UC — Umbilical Cord MSCs](https://www.organabio.com/product/mesenpac-msc-uc/): Cryopreserved umbilical cord tissue-derived mesenchymal stromal cells for regenerative medicine and cell therapy. - [MesenPAC-MSC-PL — Placenta MSCs](https://www.organabio.com/product/mesenpac-msc-pl/): Cryopreserved placenta-derived mesenchymal stromal cells for regenerative medicine and cell therapy research. ## Product Categories - [Leukopak Apheresis-Derived Products](https://www.organabio.com/product-category/leukopak-apheresis-derived-products/) - [HematoPAC HSCs and Cord Blood](https://www.organabio.com/product-category/hematopac-hscs-cord-blood/) - [ImmunoPAC Cord Blood-Derived Immune Cells](https://www.organabio.com/product-category/isolated-immune-cells/) - [MesenPAC MSCs](https://www.organabio.com/product-category/mesenchymal-stromal-cells-media/) ## Services - [Cell Processing & Cryopreservation](https://www.organabio.com/pharma-services/): Clinical cell processing, PBMC isolation, cryopreservation services for clinical trial sponsors. - [cGMP Manufacturing](https://www.organabio.com/cgmp-manufacturing/): Custom cGMP manufacturing with clinical translation capabilities. - [Assay Development & Analytical Testing](https://www.organabio.com/assay-development-and-analytical-testing/): Custom bioanalytics, immunology, and molecular biology testing. - [Process Development & Manufacturing](https://www.organabio.com/process-development-and-manufacturing/): Cell isolation, expansion, and characterization process development. - [Quality & Regulatory Compliance](https://www.organabio.com/quality-and-regulatory-compliance/): FDA-registered quality management systems. ## Pages - [Home](https://www.organabio.com/) - [About](https://www.organabio.com/about/) - [Team](https://www.organabio.com/about/team/) - [Products](https://www.organabio.com/products/) - [Product Portfolio](https://www.organabio.com/product-portfolio/) - [Services](https://www.organabio.com/services/) - [Locations](https://www.organabio.com/locations/) - [FAQ](https://www.organabio.com/frequently-asked-questions/) - [Contact](https://www.organabio.com/contact/) - [Certificate of Analysis](https://www.organabio.com/certificate-of-analysis/) - [Events](https://www.organabio.com/events/) - [Careers](https://www.organabio.com/careers/) - [PBMCs Inventory](https://www.organabio.com/pbmcs-inventory/) - [In the Media](https://www.organabio.com/in-the-media/) - [Catalogs & Brochures](https://www.organabio.com/catalogs-brochures/) ## Blog / Resources - [Perinatal Tissue Sources for Allogeneic Cell Therapy](https://www.organabio.com/perinatal-tissue-allogeneic-cell-therapy-guide/) - [Disease-State Donor Samples for Cell Therapy](https://www.organabio.com/disease-state-donor-samples-cell-therapy/) - [Co-Located Cell Collection and Processing](https://www.organabio.com/co-located-cell-collection-processing-clinical-trials/) - [What Is a Leukopak?](https://www.organabio.com/what-is-a-leukopak-and-how-do-you-source-quality-material-for-cell-therapy/) - [Breaking the Healthy Donor Paradigm: Lupus](https://www.organabio.com/breaking-the-healthy-donor-paradigm-why-lupus-patients-are-revolutionizing-cell-therapy-development/) - [The Real Cost Per Usable Cell: TCO Model](https://www.organabio.com/the-real-cost-per-usable-cell-building-a-scientist-friendly-tco-model/) - [PBMC Thaw and Recovery Guide](https://www.organabio.com/pbmc-thaw-and-recovery-the-small-moves-that-change-your-data/) - [What 30 Minutes to Process Actually Changes](https://www.organabio.com/what/) - [CD34+ HSC Isolation Determinants](https://www.organabio.com/successful-cord-blood-cd34-hsc-isolation-determinants-quality-quantity-and-timing/) - [Frozen Cellular Starting Materials: Research to Commercialization](https://www.organabio.com/from-research-to-clinical-trials-to-commercialization-advancing-cgt-with-frozen-cellular-starting-materials/) - [Cryopreservation: Freezing Time in CGT](https://www.organabio.com/cryopreservation-freezing-time-in-cell-and-gene/) - [Hidden Risks of Over-Reliance on Healthy Donor Material](https://www.organabio.com/the-hidden-risks-of-over-reliance-on-healthy-donor-material/) - [Fresh or Frozen? Cryopreservation Dilemma](https://www.organabio.com/fresh-or-frozen-navigating-the-cryopreservation-dilemma-for-cgt/) - [NK Cells: Born to Kill](https://www.organabio.com/nk-cells-born-to-kill/) - [Ethics of Cord Blood Collection](https://www.organabio.com/wait-a-minute-the-ethics-of-cord-blood-collection/) - [Lymphocytes: Adult PB vs Cord Blood](https://www.organabio.com/a-comparison-of-lymphocytes-from-adult-peripheral-blood-versus-umbilical-cord-blood/) - [The Story of T Lymphocytes](https://www.organabio.com/the-story-of-t-lymphocytes/) - [MSC-omics for Characterization](https://www.organabio.com/msc-omics-the-next-frontier-for-msc-characterization-and-standardization/) - [Case Study: Leukopaks to Singapore](https://www.organabio.com/case-study-leukopac-collections-to-singapore/) - [The OrganaBio cGMP Facility](https://www.organabio.com/the-organabio-cgmp-manufacturing-facility/) - [OrganaBio's Recallable Donor Pool](https://www.organabio.com/the-organabio-method-for-cultivation-of-a-highly-recallable-leukapheresis-donor-pool/) ## Optional - [Full details for LLMs](https://www.organabio.com/llms-full.txt) - [Sitemap](https://www.organabio.com/sitemap_index.xml)